Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Steve Bates appointed CEO of BIA

This article was originally published in Scrip

Executive Summary

After pondering the decision for three months, the BioIndustry Association has appointed Steve Bates CEO, effective from 2 July 2012. Mr Bates has worked in biotech and the highest levels of UK government for 15 years, having served as senior director of external affairs and market access at Genzyme UK and Ireland, as well as working on the establishment of the Office for Life Science. Mr Bates takes over the position from Glyn Edwards, interim CEO since April this year (scripintelligence.com, 4 April 2012).

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC017855

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel